ArticlesArchiveAboutEditorial BoardAuthor Guidelines
Call for papersThe 2026 special issue on Climate & Health is open for submissions.Learn more
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En…
K. Diabaté, H. Bakkali, A. Lachgar, S. Nadir, T. Kebdani, B. K. El Gueddari, N. Benjaafar
The purpose of this study was to update the management of invasive cervical cancers diagnosed during pregnancy. Patients and methods: This study was performed retrospectively at radiotherapy department of National Institute of Oncology Rabat Morocco. From 01/…
M. Nezami, Steve Hager, Julie Taguchi
The introduction of PARP inhibitors as active agents to inhibit the DNA repair was a revolution in the cancer therapeutics, however , such approach only has shown promising results for a short time in majority of cases due to secondary mutations and promoter…
А. N. Shchayuk, E. V. Krupnova, M. N. Shapetska, A. P. Mikhalenka, N. V. Chebotareva, A. V. Kilchevsky
Vascular endothelial growth factor (VEGF) is one of the most important and specific factors affecting angiogenesis in tumor development. VEGFR2 is a receptor encoded by the KDR gene. VEGF and VEGFR2 transmit a signal to intracellular tyrosine kinase cascades.…
Hanan Ahmed Wahba, Hend Ahmed El-Hadaad, Abeer Hussien Anter, Alaa M. Wafa, Ahmed Negm
Proper assessment of risk factors contributes to the principle management of differentiated thyroid carcinoma post operatively. Aim of the study: to investigate the effect of Thyroglobulin (Tg) levels on prognosis together with other risk factors for Differen…
M. Nezami, Steve Hager
The disagreements in clinical data and therapy recommendations extracted from different sources/studies are a common finding in oncology research. Kn owingly “biology is less reproducible than physics and mechanic engineering”, in order to overcome the disagr…
Z. Douvlis
Neoplastic cells are formed as a result of reprogramming the gene expression. It is only when these cells are classified as non-local by the normal cells that confrontation occurs, and thus cancer begins as a disease. The tumorogenic degradation of the skelet…
Ryouichi Tomita, Kenichi Sakurai, Shigeru Fujisaki, Takeo Azuhata, Yuko Takamoto
Objectives: The demerit of pylorus-preserving gastrectomy (PPG) is gastric stasis in the remnant stomach (GSRS). We investigated the relationship between postgastrectomy disorder (PGD), especially GSRS, and interdigestive migrating complex (IMC) in PPG patien…
Bing Wei, Liuhong Zeng, Di Shao, Chunting Zheng, Qing Yang, Jibin Zhang, Dong Xiao, Qiuhua Deng, Yongping Lin, Danxia Huang, Liping Liu, Xin Xu, Wenhua Liang, Chunrong Ju, Jian Wang, Karsten Kristiansen, Jianxing He, Mingzhi Ye
Background: Donor-derived cell free DNA ( ddcf DNA) has been reported as a universal noninvasive biomarker for rejection monitoring in heart, kidney, liver, and lung transplantation. Current approaches based on next-generation sequencing for quantification of…
Di Monta Gianluca, Marone Ugo, Alfonso Amore, Benedetto Lucia, Caracò Corrado
Background : Radical lymph node dissection (RLND) is the treatment of choice in stage III melanoma patients. Over half of the observed complications were related to post-operative serum collection affecting wound healing. The aim of this study was to evaluate…
Evita G. Weagel, Juan Mejía, Roman Kovtun, Joshua Keller, Juan A. Arroyo, Richard A. Robison, Kim O’Neill
Thymidine kinase 1 (TK1) is a well-studied cancer biomarker. It is commonly found upregulated in the serum of cancer patients, and its levels correlate with stage and grade, disease progression, and prognosis. It has recently been reported that TK1 localizes…
No articles in this issue.
JCT is an international journal dedicated to the latest advancements in cancer therapy. The goal of this journal is to provide a platform for doctors and academicians all over the world to promote, share, and discuss various new issues and developments in cancer related problems. All manuscripts must be prepared in En… All articles are open access under a CC BY 4.0 licence, with authors retaining copyright.
Authors submit their manuscript, metadata, and declarations through the portal. There is no submission fee.
The editorial office screens the manuscript for scope, completeness, and formatting before assigning a handling editor.
At least two independent reviewers evaluate the manuscript under single-blind review. Where revisions are required, authors respond point by point.
On acceptance the article processing charge is invoiced and the CC BY 4.0 copyright handover is signed.
The article is copyedited, typeset, and given a DOI, then publishes open access with a permanent link.
Manuscripts must be original and not under consideration elsewhere. Submit in Microsoft Word or LaTeX with figures at 300 dpi minimum. Structure research articles as Abstract, Introduction, Methods, Results, Discussion, and References.
Use the journal's numbered (Vancouver) reference style. Cite sources consecutively in the order they appear, and ensure every reference is complete and retrievable.
Declare all funding sources, conflicts of interest, and ethical approvals (including informed consent and animal-care statements where applicable).